Harmony Biosciences Holdings, Inc.
HRMY
$27.85
-$0.52-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.80% | 19.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.80% | 19.44% | |||
| Cost of Revenue | 14.91% | 56.34% | |||
| Gross Profit | -2.54% | 10.76% | |||
| SG&A Expenses | 46.14% | -7.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.96% | 14.22% | |||
| Operating Income | -41.12% | 35.92% | |||
| Income Before Tax | -39.61% | 35.97% | |||
| Income Tax Expenses | 9.92% | 68.59% | |||
| Earnings from Continuing Operations | -55.79% | 27.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -55.79% | 27.88% | |||
| EBIT | -41.12% | 35.92% | |||
| EBITDA | -35.64% | 31.96% | |||
| EPS Basic | -55.86% | 27.70% | |||
| Normalized Basic EPS | -39.69% | 35.77% | |||
| EPS Diluted | -56.17% | 27.94% | |||
| Normalized Diluted EPS | -39.59% | 35.29% | |||
| Average Basic Shares Outstanding | 0.15% | 0.14% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||